Xvivo Perfusion AB (publ) (STO:XVIVO)

Xvivo Perfusion AB Revenue

Xvivo Perfusion AB had revenue of 240.96M SEK in the quarter ending March 31, 2026, with 10.23% growth. This brings the company's revenue in the last twelve months to 834.53M, down -2.39% year-over-year. In the year 2025, Xvivo Perfusion AB had annual revenue of 812.17M, down -1.25%.

• Revenue (ttm): 834.53M
• Revenue Growth: -2.39%
• P/S Ratio: 10.34
• Revenue / Employee: 4.19M
• Employees: 200
• Market Cap: 8.63B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	812.17M	-10.25M	-1.25%
Dec 31, 2024	822.42M	224.87M	37.63%
Dec 31, 2023	597.54M	182.25M	43.88%
Dec 31, 2022	415.29M	156.91M	60.73%
Dec 31, 2021	258.39M	78.53M	43.66%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 30, 2026

Data Sources Report a data error